5,7-Dibromoisatin - CAS 6374-91-0
Catalog: |
BB032256 |
Product Name: |
5,7-Dibromoisatin |
CAS: |
6374-91-0 |
Synonyms: |
5,7-dibromo-1H-indole-2,3-dione |
IUPAC Name: | 5,7-dibromo-1H-indole-2,3-dione |
Description: | 5,7-Dibromoisatin (CAS# 6374-91-0) is a useful research chemical. |
Molecular Weight: | 304.92 |
Molecular Formula: | C8H3Br2NO2 |
Canonical SMILES: | C1=C(C=C2C(=C1Br)NC(=O)C2=O)Br |
InChI: | InChI=1S/C8H3Br2NO2/c9-3-1-4-6(5(10)2-3)11-8(13)7(4)12/h1-2H,(H,11,12,13) |
InChI Key: | QCTZEHIRXZGGSD-UHFFFAOYSA-N |
Appearance: | Solid |
MDL: | MFCD00034382 |
LogP: | 2.48440 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2020219531-A1 | Methods and compositions relating to inhibition of aldehyde dehydrogenases for treatment of cancer | 20190422 |
WO-2020183307-A1 | Dihydro-spiro[indoline-3:1'-isoquinolin]-2-ones and their analogues and derivatives and methods of treating cancer and other diseases | 20190308 |
US-10611786-B2 | Manganese (III) catalyzed Câ€"H aminations | 20171009 |
US-2019106448-A1 | Manganese (iii) catalyzed c--h aminations | 20171009 |
CN-105541808-A | Metronidazole-isatin type compound as well as preparation method and application thereof | 20160204 |
PMID | Publication Date | Title | Journal |
22496857 | 20120101 | Modulation of GSK-3β activity in Venezuelan equine encephalitis virus infection | PloS one |
21920762 | 20111015 | Synthesis and biological evaluation of a novel class of isatin analogs as dual inhibitors of tubulin polymerization and Akt pathway | Bioorganic & medicinal chemistry |
21306903 | 20110301 | Synthesis and hydrolytic evaluation of acid-labile imine-linked cytotoxic isatin model systems | Bioorganic & medicinal chemistry |
20056518 | 20100301 | QSAR study of isatin analogues as in vitro anti-cancer agents | European journal of medicinal chemistry |
18182300 | 20080315 | N-phenethyl and N-naphthylmethyl isatins and analogues as in vitro cytotoxic agents | Bioorganic & medicinal chemistry |
Complexity: | 269 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 304.851 |
Formal Charge: | 0 |
Heavy Atom Count: | 13 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 302.85305 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 46.2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Indoles
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS